Literature DB >> 8088298

Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).

E Jacquemin1, M Dumont, O Bernard, S Erlinger, M Hadchouel.   

Abstract

To clarify the relationship of progressive familial intrahepatic cholestasis (Byler disease) to bile acid metabolism, we analysed, by high performance liquid chromatography, the bile acid composition of serum and bile in seven children with Byler disease and in eight control children with other cholestatic diseases. In serum, total bile acid concentration was increased in patients with Byler disease (0.30 +/- 0.05 mmol/l) and in control patients (0.21 +/- 0.08 mmol/l). Cholate (C) and chenodeoxycholate (CDC) comprised the major proportion of total bile acids in patients with Byler disease as in control patients. Hyocholate (HC) was only detected in patients with Byler disease and lithocholate was only present in control children. In bile, total bile acid concentration was very low in patients with Byler disease (1.1 +/- 1.4 mmol/l) compared to control patients (88.9 +/- 83.2 mmol/l). C and CDC were the major bile acids in control patients, whereas C and HC comprised the major proportion of bile acids in patients with Byler disease. These results suggest the existence of a defect of primary bile acid secretion in Byler disease characterized by the presence of high concentration of bile acids in serum and absence or very low concentration of bile acids in bile.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088298     DOI: 10.1007/bf01983406

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  27 in total

1.  ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles.

Authors:  B Stieger; B O'Neill; P J Meier
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

Review 2.  Transport polarity of hepatocytes.

Authors:  P J Meier
Journal:  Semin Liver Dis       Date:  1988-11       Impact factor: 6.115

3.  Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism.

Authors:  Z R Vlahcevic; P Juttijudata; C C Bell; L Swell
Journal:  Gastroenterology       Date:  1972-06       Impact factor: 22.682

4.  Mechanism of phenobarbital-induced hypercholeresis in the rat.

Authors:  P Berthelot; S Erlinger; D Dhumeaux; A M Preaux
Journal:  Am J Physiol       Date:  1970-09

5.  Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment.

Authors:  A Stiehl; M Becker; P Czygan; W Fröhling; B Kommerell; H W Rotthauwe; M Senn
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

6.  Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man.

Authors:  E Sacquet; M Parquet; M Riottot; A Raizman; P Jarrige; C Huguet; R Infante
Journal:  J Lipid Res       Date:  1983-05       Impact factor: 5.922

Review 7.  Determinants of bile formation during development: ontogeny of hepatic bile acid metabolism and transport.

Authors:  F J Suchy; J C Bucuvalas; D A Novak
Journal:  Semin Liver Dis       Date:  1987-05       Impact factor: 6.115

8.  Properties of the canalicular bile acid transport system in rat liver.

Authors:  P J Meier; A S Meier-Abt; J L Boyer
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

Review 9.  Familial intrahepatic cholestatic syndromes.

Authors:  C A Riely
Journal:  Semin Liver Dis       Date:  1987-05       Impact factor: 6.115

10.  Similarity of unusual bile acids in human umbilical cord blood and amniotic fluid from newborns and in sera and urine from adult patients with cholestatic liver diseases.

Authors:  J Shoda; R Mahara; T Osuga; M Tohma; S Ohnishi; H Miyazaki; N Tanaka; Y Matsuzaki
Journal:  J Lipid Res       Date:  1988-07       Impact factor: 5.922

View more
  10 in total

1.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

2.  Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Lauren N Bell; Jacob Wulff; Megan Comerford; Raj Vuppalanchi; Naga Chalasani
Journal:  Liver Int       Date:  2014-09-22       Impact factor: 5.828

3.  Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion.

Authors:  Hilary S Jericho; Elizabeth Kaurs; Renze Boverhof; Alex Knisely; Benjamin L Shneider; Henkjan J Verkade; Peter F Whitington
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

4.  Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.

Authors:  J M de Vree; E Jacquemin; E Sturm; D Cresteil; P J Bosma; J Aten; J F Deleuze; M Desrochers; M Burdelski; O Bernard; R P Oude Elferink; M Hadchouel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  Byler-like familial cholestasis in an extended kindred.

Authors:  B Bourke; N Goggin; D Walsh; S Kennedy; K D Setchell; B Drumm
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

Review 6.  Partial external biliary diversion for the treatment of intractable pruritus in children with progressive familial intrahepatic cholestasis: report of two cases.

Authors:  Saniye Ekinci; Ibrahim Karnak; Figen Gürakan; Aysel Yüce; Mehmet Emin Senocak; F Cahit Tanyel; Nebil Büyükpamukçu
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

7.  Anaesthetic considerations in progressive familial intrahepatic cholestasis (Byler's disease).

Authors:  G Müller; F Veyckemans; M Calier; L J Van Obbergh; M De Kock; E M Sokal; J B Otte
Journal:  Can J Anaesth       Date:  1995-12       Impact factor: 5.063

8.  Clinical challenge in hepatology.

Authors:  Alireza Norouzi; Sadaf Ghajarieh Sepanlou; Samaneh Tavassoli; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2011-09

Review 9.  Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature.

Authors:  Giovanni Vitale; Alessandro Mattiaccio; Amalia Conti; Laura Turco; Marco Seri; Fabio Piscaglia; Maria Cristina Morelli
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

10.  Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion.

Authors:  Karan M Emerick; Marc S Elias; Hector Melin-Aldana; Sandra Strautnieks; Richard J Thompson; Laura N Bull; A s Knisely; Peter F Whitington; Richard M Green
Journal:  BMC Gastroenterol       Date:  2008-10-20       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.